Divestments

Biovian

Biovian is a market leader within in contract manufacturing and development of biopharmaceuticals

Founded in 2003 and based in Turku, Finland, Biovian offers outsourcing services in process development and contract manufacturing for small and medium size biotechnology firms and has deep industry expertise across different key biological processes.

  • Sector
    Healthcare
  • Country
    Finland
  • Fund
    EQT Mid-Market Credit,EQT Mid-Market Credit II
  • Entry
    2018
  • Exit
    2020-10-01

With main operations in Europe, the US and South Korea, the company benefits from a strong Biotech pipeline, fueled by new biologic products progressively replacing traditional pharma.

EQT Credit provided a Unitranche financing to support Keensight and ERES’ acquisition of Biovian, which is expected to continue to benefit from the attractive growth characteristics of the biopharma market.

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language
EQT logo
A purpose-driven global investment organization
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180